Effect of food on the bioavailability of 100-mg Dilantin kapseals

Neurology

Volumn 57, Issue 4, 2001, Pages 698-700

  Cook, Jack ^a   Randinitis, Edward ^a   Wilder, B J ^b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DILANTIN KAPSEAL; PHENYTOIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; FEMALE; FOOD; FOOD AND DRUG ADMINISTRATION; FOOD DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEADY STATE;

EID: 0035964318     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.4.698     Document Type: Article

References (7)

1. Sensitivity analysis of the effect of bioavailability or dosage form content on mean steady state phenytoin concentration
2. Pharmacokinetic profile of a 300-mg extended phenytoin sodium capsule (Dilantin) formulation
3. The effect of food on the absorption of phenytoin
4. Effect of food on absorption of Dilantin Kapseals and Mylan extended phenytoin sodium capsules
5. Influence of food on the absorption of phenytoin in man